The effect of nonuniform magnetic targeting of intracoronary-delivering mesenchymal stem cells on coronary embolisation

Biomaterials

Volumn 34, Issue 38, 2013, Pages 9905-9916

  Huang, Zheyong ^a   Shen, Yunli ^a   Pei, Ning ^b   Sun, Aijun ^a   Xu, Jianfeng ^a   Song, Yanan ^a   Huang, Gangyong ^c   Sun, Xiaoning ^a   Zhang, Shuning ^a   Qin, Qing ^a   Zhu, Hongming ^a   Yang, Shan ^a   Yang, Xiangdong ^a   Zou, Yunzeng ^a   Qian, Juying ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Coronary artery; Embolisation; Magnetic targeting; Nanoparticle; Stem cell

Indexed keywords

ACUTE MYOCARDIAL INFARCTION; CLINICAL APPLICATION; CORONARY ARTERIES; EMBOLISATION; INHOMOGENEOUS DISTRIBUTION; MAGNETIC TARGETING; MESENCHYMAL STEM CELL; PERMANENT MAGNETIC FIELDS;

FLOWCHARTING; NANOMAGNETICS; NANOPARTICLES; STEM CELLS;

CELL CULTURE;

IRON OXIDE;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FINITE ELEMENT ANALYSIS; GENE DELIVERY SYSTEM; IN VITRO STUDY; INTRACAVITARY DRUG ADMINISTRATION; MAGNET; MAGNETIC FIELD; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RADIATION ATTENUATION; RANDOMIZED CONTROLLED TRIAL; RAT;

ANIMALIA; RATTUS;

B; CAPTURE EFFICIENCY; CE; CORONARY ARTERY; EMBOLISATION; F(R); I/R; IC; INTRACORONARY INJECTION; ISCHEMIA/REPERFUSION; MAGMSCS; MAGNETIC FIELD DENSITY; MAGNETIC FIELD GRADIENT IN R DIRECTION; MAGNETIC FORCE ON CELLS IN R DIRECTION; MAGNETIC RESONANCE; MAGNETIC TARGETING; MAGNETICALLY-LOADED MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELLS; MNCS; MONONUCLEAR CELLS; MR; MSCS; NANOPARTICLE; NDFEB; NEODYMIUM-IRON-BORON; PLL; POLY-L-LYSINE; SEX-DETERMINING REGION Y GENE; SPIO; SRY; STEM CELL; SUPERPARAMAGNETIC OXIDE NANOPARTICLES; ∂B/∂R;

ANIMALS; CELLS, CULTURED; CORONARY VESSELS; MALE; MESENCHYMAL STROMAL CELLS; NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS;

EID: 84885371788     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.092     Document Type: Article

References (33)

1. Fukushima S., Varela-Carver A., Coppen S.R., Yamahara K., Felkin L.E., Lee J., et al. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 2007, 115:2254-2261.
2. Toma C., Wagner W.R., Bowry S., Schwartz A., Villanueva F. Fate of culture-expanded mesenchymal stem cells in the microvasculature: invivo observations of cell kinetics. Circ Res 2009, 104:398-402.
3. Furlani D., Ugurlucan M., Ong L., Bieback K., Pittermann E., Westien I., et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res 2009, 77:370-376.
4. Langer R. Drug delivery. Drugs on target. Science 2001, 293:58-59.
5. Kim J.A., Lee H.J., Kang H.J., Park T.H. The targeting of endothelial progenitor cells to a specific location within a microfluidic channel using magnetic nanoparticles. Biomed Microdevices 2009, 11:287-296.
6. Pislaru S.V., Harbuzariu A., Gulati R., Witt T., Sandhu N.P., Simari R.D., et al. Magnetically targeted endothelial cell localization in stented vessels. JAm Coll Cardiol 2006, 48:1839-1845.
7. Polyak B., Fishbein I., Chorny M., Alferiev I., Williams D., Yellen B., et al. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc Natl Acad Sci U S A 2008, 105:698-703.
8. Darton N.J., Hallmark B., Han X., Palit S., Slater N.K., Mackley M.R. The in-flow capture of superparamagnetic nanoparticles for targeting therapeutics. Nanomedicine 2008, 4:19-29.
9. Kobayashi T., Ochi M., Yanada S., Ishikawa M., Adachi N., Deie M., et al. Anovel cell delivery system using magnetically labeled mesenchymal stem cells and an external magnetic device for clinical cartilage repair. Arthroscopy 2008, 24:69-76.
10. Kobayashi T., Ochi M., Yanada S., Ishikawa M., Adachi N., Deie M., et al. Augmentation of degenerated human cartilage invitro using magnetically labeled mesenchymal stem cells and an external magnetic device. Arthroscopy 2009, 25:1435-1441.
11. Sugioka T., Ochi M., Yasunaga Y., Adachi N., Yanada S. Accumulation of magnetically labeled rat mesenchymal stem cells using an external magnetic force, and their potential for bone regeneration. JBiomed Mater Res A 2008, 85:597-604.
12. Wilhelm C., Bal L., Smirnov P., Galy-Fauroux I., Clement O., Gazeau F., et al. Magnetic control of vascular network formation with magnetically labeled endothelial progenitor cells. Biomaterials 2007, 28:3797-3806.
13. Huang Z., Pei N., Wang Y., Xie X., Sun A., Shen L., et al. Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics. Biomaterials 2010, 31:2130-2140.
14. Chaudeurge A., Wilhelm C., Chen-Tournoux A., Farahmand P., Bellamy V., Autret G., et al. Can magnetic targeting of magnetically labeled circulating cells optimize intramyocardial cell retention?. Cell Transplant 2012, 21:679-691.
15. Cheng K., Malliaras K., Li T.S., Sun B., Houde C., Galang G., et al. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant 2012, 21:1121-1135.
16. Lencioni R., Bartolozzi C. Clinical impact of Resovist-enhanced MRI: results of an Italian multicenter trial. Eur Radiol 2004, 14(Suppl.1):C10.
17. Reimer P., Rummeny E.J., Daldrup H.E., Balzer T., Tombach B., Berns T., et al. Clinical results with Resovist: a phase 2 clinical trial. Radiology 1995, 195:489-496.
18. Xie X., Sun A., Zhu W., Huang Z., Hu X., Jia J., et al. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats. Tohoku J Exp Med 2012, 226:29-36.
19. Molina E.J., Palma J., Gupta D., Gaughan J.P., Houser S., Macha M. Right ventricular effects of intracoronary delivery of mesenchymal stem cells (MSC) in an animal model of pressure overload heart failure. Biomed Pharmacother 2009, 63:767-772.
20. Molina E.J., Palma J., Gupta D., Torres D., Gaughan J.P., Houser S., et al. Improvement in hemodynamic performance, exercise capacity, inflammatory profile, and left ventricular reverse remodeling after intracoronary delivery of mesenchymal stem cells in an experimental model of pressure overload hypertrophy. JThorac Cardiovasc Surg 2008, 135:292-299. 299 e291.
21. Cheng K., Li T.S., Malliaras K., Davis D.R., Zhang Y., Marban E. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 2010, 106:1570-1581.
22. Terrovitis J.V., Smith R.R., Marban E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 2010, 106:479-494.
23. Wang X., Jameel M.N., Li Q., Mansoor A., Qiang X., Swingen C., et al. Stem cells for myocardial repair with use of a transarterial catheter. Circulation 2009, 120:S238-S246.
24. Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., et al. Therapeutic potential of exvivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103:634-637.
25. Tang X.L., Rokosh G., Sanganalmath S.K., Yuan F., Sato H., Mu J., et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 2010, 121:293-305.
26. Huang Z., Pei N., Wang Y., Xie X., Sun A., Shen L., et al. Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics. Biomaterials 2010, 31:1206-1216.
27. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106:1913-1918.
28. Britten M.B., Abolmaali N.D., Assmus B., Lehmann R., Honold J., Schmitt J., et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003, 108:2212-2218.
29. Vulliet P.R., Greeley M., Halloran S.M., MacDonald K.A., Kittleson M.D. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004, 363:783-784.
30. Nakamae T., Adachi N., Kobayashi T., Nagata Y., Nakasa T., Tanaka N., et al. The effect of an external magnetic force on cell adhesion and proliferation of magnetically labeled mesenchymal stem cells. Sports Med Arthrosc Rehabil Ther Technol 2010, 2:5.
31. Stephenne X., Nicastro E., Eeckhoudt S., Hermans C., Nyabi O., Lombard C., et al. Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity. PLoS One 2012, 7:e42819.
32. Simberg D., Duza T., Park J.H., Essler M., Pilch J., Zhang L., et al. Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci U S A 2007, 104:932-936.
33. Huang Z., Pei N., Shen Y., Gong Y., Xie X., Sun X., et al. Anovel method to delivery stem cells to the injured heart: spatially focused magnetic targeting strategy. JCell Mol Med 2012, 16:1203-1205.